{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:46:25Z","timestamp":1794271585487,"version":"4.9.0"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41577-022-00727-y","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T09:04:52Z","timestamp":1652087092000},"page":"9-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":360,"title":["The impact of the gut microbiome on extra-intestinal autoimmune diseases"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8202-684X","authenticated-orcid":false,"given":"Eiji","family":"Miyauchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Steimle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-2209","authenticated-orcid":false,"given":"Mahesh S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-9661","authenticated-orcid":false,"given":"Hiroshi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"727_CR1","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1001\/jama.2018.7028","volume":"319","author":"H Song","year":"2018","unstructured":"Song, H. et al. Association of stress-related disorders with subsequent autoimmune disease. JAMA 319, 2388\u20132400 (2018).","journal-title":"JAMA"},{"key":"727_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2014.05.014","volume":"40","author":"AN Thorburn","year":"2014","unstructured":"Thorburn, A. N., Macia, L. & Mackay, C. R. Diet, metabolites, and \u201cwestern-lifestyle\u201d inflammatory diseases. Immunity 40, 833\u2013842 (2014).","journal-title":"Immunity"},{"key":"727_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nri.2017.111","volume":"18","author":"JF Bach","year":"2018","unstructured":"Bach, J. F. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat. Rev. Immunol. 18, 105\u2013120 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"727_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59\u201365 (2010).","journal-title":"Nature"},{"key":"727_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"International Multiple Sclerosis Genetics Consortium.","year":"2011","unstructured":"International Multiple Sclerosis Genetics Consortium. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214\u2013219 (2011).","journal-title":"Nature"},{"key":"727_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/ane.12431","volume":"132","author":"J Correale","year":"2015","unstructured":"Correale, J. & Gaitan, M. I. Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection. Acta Neurol. Scand. 132, 46\u201355 (2015).","journal-title":"Acta Neurol. Scand."},{"key":"727_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.coi.2016.09.002","volume":"43","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer, V. & Quintana, F. J. Environmental control of autoimmune inflammation in the central nervous system. Curr. Opin. Immunol. 43, 46\u201353 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"727_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2007.09.009","volume":"191","author":"T Korn","year":"2007","unstructured":"Korn, T., Anderson, A. C., Bettelli, E. & Oukka, M. The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J. Neuroimmunol. 191, 51\u201360 (2007).","journal-title":"J. Neuroimmunol."},{"key":"727_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/gene.2016.23","volume":"17","author":"JP Hussman","year":"2016","unstructured":"Hussman, J. P. et al. GWAS analysis implicates NF-kappaB-mediated induction of inflammatory T cells in multiple sclerosis. Genes Immun. 17, 305\u2013312 (2016).","journal-title":"Genes Immun."},{"key":"727_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molmed.2009.12.003","volume":"16","author":"K Venken","year":"2010","unstructured":"Venken, K., Hellings, N., Liblau, R. & Stinissen, P. Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol. Med. 16, 58\u201368 (2010).","journal-title":"Trends Mol. Med."},{"key":"727_CR11","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer, K. et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479, 538\u2013541 (2011).","journal-title":"Nature"},{"key":"727_CR12","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2353\/ajpath.2008.080622","volume":"173","author":"H Yokote","year":"2008","unstructured":"Yokote, H. et al. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am. J. Pathol. 173, 1714\u20131723 (2008).","journal-title":"Am. J. Pathol."},{"key":"727_CR13","doi-asserted-by":"publisher","first-page":"e0137429","DOI":"10.1371\/journal.pone.0137429","volume":"10","author":"S Miyake","year":"2015","unstructured":"Miyake, S. et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One 10, e0137429 (2015).","journal-title":"PLoS One"},{"key":"727_CR14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446\u2013450 (2013).","journal-title":"Nature"},{"key":"727_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","volume":"500","author":"K Atarashi","year":"2013","unstructured":"Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232\u2013236 (2013).","journal-title":"Nature"},{"key":"727_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi, S. et al. Alterations of the human gut microbiome in multiple sclerosis. Nat. Commun. 7, 12015 (2016).","journal-title":"Nat. Commun."},{"key":"727_CR17","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.1073\/pnas.1711233114","volume":"114","author":"K Berer","year":"2017","unstructured":"Berer, K. et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc. Natl Acad. Sci. USA 114, 10719\u201310724 (2017). This study shows the relationship between dysbiosis in patients with MS and disease progression by FMT into disease model mice.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep28484","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci. Rep. 6, 28484 (2016).","journal-title":"Sci. Rep."},{"key":"727_CR19","doi-asserted-by":"publisher","first-page":"e1700492","DOI":"10.1126\/sciadv.1700492","volume":"3","author":"I Cosorich","year":"2017","unstructured":"Cosorich, I. et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci. Adv. 3, e1700492 (2017). This is the demonstration of microbiota composition and immune cells in the small intestine of patients with MS.","journal-title":"Sci. Adv."},{"key":"727_CR20","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute, E. et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc. Natl Acad. Sci. USA 114, 10713\u201310718 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52894-z","volume":"9","author":"RE Ventura","year":"2019","unstructured":"Ventura, R. E. et al. Gut microbiome of treatment-naive MS patients of different ethnicities early in disease course. Sci. Rep. 9, 16396 (2019).","journal-title":"Sci. Rep."},{"key":"727_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nbt.3960","volume":"35","author":"PI Costea","year":"2017","unstructured":"Costea, P. I. et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069\u20131076 (2017).","journal-title":"Nat. Biotechnol."},{"key":"727_CR23","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.celrep.2017.07.031","volume":"20","author":"A Mangalam","year":"2017","unstructured":"Mangalam, A. et al. Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease. Cell Rep. 20, 1269\u20131277 (2017).","journal-title":"Cell Rep."},{"key":"727_CR24","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.immuni.2011.03.021","volume":"34","author":"MB Geuking","year":"2011","unstructured":"Geuking, M. B. et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34, 794\u2013806 (2011).","journal-title":"Immunity"},{"key":"727_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molmed.2021.10.004","volume":"28","author":"A Parrish","year":"2022","unstructured":"Parrish, A., Boudaud, M., Kuehn, A., Ollert, M. & Desai, M. S. Intestinal mucus barrier: a missing piece of the puzzle in food allergy. Trends Mol. Med. 28, 36\u201350 (2022).","journal-title":"Trends Mol. Med."},{"key":"727_CR26","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","volume":"167","author":"MS Desai","year":"2016","unstructured":"Desai, M. S. et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167, 1339\u20131353.e21 (2016).","journal-title":"Cell"},{"key":"727_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"NR Shin","year":"2014","unstructured":"Shin, N. R. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727\u2013735 (2014).","journal-title":"Gut"},{"key":"727_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91\u201397 (2018).","journal-title":"Science"},{"key":"727_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.celrep.2017.03.080","volume":"19","author":"SS Seregin","year":"2017","unstructured":"Seregin, S. S. et al. NLRP6 Protects Il10\u2212\/\u2212 mice from colitis by limiting colonization of Akkermansia muciniphila. Cell Rep. 19, 733\u2013745 (2017).","journal-title":"Cell Rep."},{"key":"727_CR30","first-page":"447","volume":"85","author":"JM Rodgers","year":"2012","unstructured":"Rodgers, J. M. & Miller, S. D. Cytokine control of inflammation and repair in the pathology of multiple sclerosis. Yale J. Biol. Med. 85, 447\u2013468 (2012).","journal-title":"Yale J. Biol. Med."},{"key":"727_CR31","doi-asserted-by":"publisher","first-page":"e104306","DOI":"10.1371\/journal.pone.0104306","volume":"9","author":"SA Engen","year":"2014","unstructured":"Engen, S. A. et al. The oral commensal Streptococcus mitis shows a mixed memory Th cell signature that is similar to and cross-reactive with Streptococcus pneumoniae. PLoS One 9, e104306 (2014).","journal-title":"PLoS One"},{"key":"727_CR32","doi-asserted-by":"publisher","first-page":"369ra176","DOI":"10.1126\/scitranslmed.aaj1921","volume":"8","author":"MF Konig","year":"2016","unstructured":"Konig, M. F. et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci. Transl. Med. 8, 369ra176 (2016).","journal-title":"Sci. Transl. Med."},{"key":"727_CR33","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21, 895\u2013905 (2015).","journal-title":"Nat. Med."},{"key":"727_CR34","doi-asserted-by":"publisher","first-page":"491160","DOI":"10.3389\/fcimb.2020.491160","volume":"10","author":"M Vural","year":"2020","unstructured":"Vural, M., Gilbert, B., Ustun, I., Caglar, S. & Finckh, A. Mini-review: human microbiome and rheumatic diseases. Front Cell Infect. Microbiol. 10, 491160 (2020).","journal-title":"Front Cell Infect. Microbiol."},{"key":"727_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.0954-6820.1968.tb02478.x","volume":"184","author":"B Olhagen","year":"1968","unstructured":"Olhagen, B. & Mansson, I. Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases. Acta Med. Scand. 184, 395\u2013402 (1968).","journal-title":"Acta Med. Scand."},{"key":"727_CR36","doi-asserted-by":"publisher","first-page":"e01202","DOI":"10.7554\/eLife.01202","volume":"2","author":"JU Scher","year":"2013","unstructured":"Scher, J. U. et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2, e01202 (2013).","journal-title":"eLife"},{"key":"727_CR37","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1002\/art.39783","volume":"68","author":"Y Maeda","year":"2016","unstructured":"Maeda, Y. et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. 68, 2646\u20132661 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"727_CR38","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/annrheumdis-2018-214514","volume":"78","author":"D Alpizar-Rodriguez","year":"2019","unstructured":"Alpizar-Rodriguez, D. et al. Prevotella copri in individuals at risk for rheumatoid arthritis. Ann. Rheum. Dis. 78, 590\u2013593 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"727_CR39","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1002\/art.39785","volume":"68","author":"EV Marietta","year":"2016","unstructured":"Marietta, E. V. et al. Suppression of inflammatory arthritis by human gut-derived Prevotella histicola in humanized mice. Arthritis Rheumatol. 68, 2878\u20132888 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"727_CR40","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/art.40003","volume":"69","author":"A Pianta","year":"2017","unstructured":"Pianta, A. et al. Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis. Arthritis Rheumatol. 69, 964\u2013975 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"727_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/annrheumdis-2019-215743","volume":"79","author":"T Kishikawa","year":"2020","unstructured":"Kishikawa, T. et al. Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population. Ann. Rheum. Dis. 79, 103\u2013111 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"727_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15831-7","volume":"11","author":"N Tajik","year":"2020","unstructured":"Tajik, N. et al. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat. Commun. 11, 1995 (2020). The authors show that the microbiota composition and SCFAs are altered just before disease onset in RA model mice.","journal-title":"Nat. Commun."},{"key":"727_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0299-7","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 8, 43 (2016).","journal-title":"Genome Med."},{"key":"727_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0283-6","volume":"51","author":"Y Maeda","year":"2019","unstructured":"Maeda, Y. & Takeda, K. Host-microbiota interactions in rheumatoid arthritis. Exp. Mol. Med. 51, 1\u20136 (2019).","journal-title":"Exp. Mol. Med."},{"key":"727_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fendo.2017.00343","volume":"8","author":"AL Burrack","year":"2017","unstructured":"Burrack, A. L., Martinov, T. & Fife, B. T. T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol. 8, 343 (2017).","journal-title":"Front Endocrinol."},{"key":"727_CR46","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s001250051214","volume":"42","author":"M Schenker","year":"1999","unstructured":"Schenker, M. et al. Early expression and high prevalence of islet autoantibodies for DR3\/4 heterozygous and DR4\/4 homozygous offspring of parents with type I diabetes: the German BABYDIAB study. Diabetologia 42, 671\u2013677 (1999).","journal-title":"Diabetologia"},{"key":"727_CR47","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1001\/jama.2014.5610","volume":"311","author":"M Knip","year":"2014","unstructured":"Knip, M. et al. Hydrolyzed infant formula and early beta-cell autoimmunity: a randomized clinical trial. JAMA 311, 2279\u20132287 (2014).","journal-title":"JAMA"},{"key":"727_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2337\/dc14-1130","volume":"38","author":"NA Lund-Blix","year":"2015","unstructured":"Lund-Blix, N. A. et al. Infant feeding in relation to islet autoimmunity and type 1 diabetes in genetically susceptible children: the MIDIA Study. Diabetes Care 38, 257\u2013263 (2015).","journal-title":"Diabetes Care"},{"key":"727_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12876-016-0498-0","volume":"16","author":"E Rutayisire","year":"2016","unstructured":"Rutayisire, E., Huang, K., Liu, Y. & Tao, F. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants\u2019 life: a systematic review. BMC Gastroenterol. 16, 86 (2016).","journal-title":"BMC Gastroenterol."},{"key":"727_CR50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/dme.13262","volume":"34","author":"KH Mikkelsen","year":"2017","unstructured":"Mikkelsen, K. H. et al. Use of antibiotics in childhood and risk of type 1 diabetes: a population-based case-control study. Diabet. Med. 34, 272\u2013277 (2017). This longitudinal cohort study highlights the alteration of gut bacterial gene content and metabolites before T1D onset.","journal-title":"Diabet. Med."},{"key":"727_CR51","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.2337\/db14-1847","volume":"64","author":"AK Alkanani","year":"2015","unstructured":"Alkanani, A. K. et al. Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes 64, 3510\u20133520 (2015).","journal-title":"Diabetes"},{"key":"727_CR52","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.chom.2015.01.001","volume":"17","author":"AD Kostic","year":"2015","unstructured":"Kostic, A. D. et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17, 260\u2013273 (2015).","journal-title":"Cell Host Microbe"},{"key":"727_CR53","doi-asserted-by":"publisher","first-page":"e25792","DOI":"10.1371\/journal.pone.0025792","volume":"6","author":"CT Brown","year":"2011","unstructured":"Brown, C. T. et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 6, e25792 (2011).","journal-title":"PLoS One"},{"key":"727_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep03814","volume":"4","author":"ME Mejia-Leon","year":"2014","unstructured":"Mejia-Leon, M. E., Petrosino, J. F., Ajami, N. J., Dominguez-Bello, M. G. & de la Barca, A. M. Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci. Rep. 4, 3814 (2014).","journal-title":"Sci. Rep."},{"key":"727_CR55","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3389\/fmicb.2014.00678","volume":"5","author":"AG Davis-Richardson","year":"2014","unstructured":"Davis-Richardson, A. G. et al. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front. Microbiol. 5, 678 (2014).","journal-title":"Front. Microbiol."},{"key":"727_CR56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41586-018-0620-2","volume":"562","author":"T Vatanen","year":"2018","unstructured":"Vatanen, T. et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562, 589\u2013594 (2018).","journal-title":"Nature"},{"key":"727_CR57","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-018-0617-x","volume":"562","author":"CJ Stewart","year":"2018","unstructured":"Stewart, C. J. et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 562, 583\u2013588 (2018).","journal-title":"Nature"},{"key":"727_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.282","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot, C. et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp. Mol. Med. 50, e450 (2018).","journal-title":"Exp. Mol. Med."},{"key":"727_CR59","first-page":"574","volume":"20","author":"JE Harbison","year":"2019","unstructured":"Harbison, J. E. et al. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: a prospective cohort study. Pediatr. Diabetes 20, 574\u2013583 (2019).","journal-title":"Pediatr. Diabetes"},{"key":"727_CR60","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.berh.2018.09.004","volume":"32","author":"I Gergianaki","year":"2018","unstructured":"Gergianaki, I., Bortoluzzi, A. & Bertsias, G. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best. Pract. Res. Clin. Rheumatol. 32, 188\u2013205 (2018).","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"727_CR61","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"393","author":"T Dorner","year":"2019","unstructured":"Dorner, T. & Furie, R. Novel paradigms in systemic lupus erythematosus. Lancet 393, 2344\u20132358 (2019).","journal-title":"Lancet"},{"key":"727_CR62","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature24302","volume":"551","author":"S Shalapour","year":"2017","unstructured":"Shalapour, S. et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature 551, 340\u2013345 (2017).","journal-title":"Nature"},{"key":"727_CR63","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fimmu.2015.00608","volume":"6","author":"Q Mu","year":"2015","unstructured":"Mu, Q., Zhang, H. & Luo, X. M. SLE: another autoimmune disorder influenced by microbes and diet? Front. Immunol. 6, 608 (2015).","journal-title":"Front. Immunol."},{"key":"727_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02288-17","author":"XM Luo","year":"2018","unstructured":"Luo, X. M. et al. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl. Environ. Microbiol. https:\/\/doi.org\/10.1128\/AEM.02288-17 (2018).","journal-title":"Appl. Environ. Microbiol."},{"key":"727_CR65","doi-asserted-by":"publisher","first-page":"e01548-14","DOI":"10.1128\/mBio.01548-14","volume":"5","author":"A Hevia","year":"2014","unstructured":"Hevia, A. et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio 5, e01548-14 (2014).","journal-title":"mBio"},{"key":"727_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-016-0146-9","volume":"8","author":"Z He","year":"2016","unstructured":"He, Z., Shao, T., Li, H., Xie, Z. & Wen, C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog. 8, 64 (2016).","journal-title":"Gut Pathog."},{"key":"727_CR67","doi-asserted-by":"publisher","first-page":"eaan2306","DOI":"10.1126\/scitranslmed.aan2306","volume":"10","author":"TM Greiling","year":"2018","unstructured":"Greiling, T. M. et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci. Transl. Med. 10, eaan2306 (2018). The authors clearly demonstrate the cross-reactivity of autoimmune T cells in patients with SLE with gut commensals.","journal-title":"Sci. Transl. Med."},{"key":"727_CR68","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.10.009","volume":"97","author":"TA van der Meulen","year":"2019","unstructured":"van der Meulen, T. A. et al. Shared gut, but distinct oral microbiota composition in primary Sjogren\u2019s syndrome and systemic lupus erythematosus. J. Autoimmun. 97, 77\u201387 (2019).","journal-title":"J. Autoimmun."},{"key":"727_CR69","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","volume":"78","author":"D Azzouz","year":"2019","unstructured":"Azzouz, D. et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann. Rheum. Dis. 78, 947\u2013956 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"727_CR70","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jdcr.2019.05.022","volume":"5","author":"A Al Khalili","year":"2019","unstructured":"Al Khalili, A., Scott, L. & Dutz, J. P. New-onset autoantibody-mediated nephritis during ustekinumab therapy for psoriasis in patients with and without prior systemic lupus erythematosus. JAAD Case Rep. 5, 682\u2013685 (2019).","journal-title":"JAAD Case Rep."},{"key":"727_CR71","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s13311-017-0582-3","volume":"15","author":"MC Buscarinu","year":"2018","unstructured":"Buscarinu, M. C. et al. Intestinal permeability in relapsing-remitting multiple sclerosis. Neurotherapeutics 15, 68\u201374 (2018).","journal-title":"Neurotherapeutics"},{"key":"727_CR72","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12016-011-8291-x","volume":"42","author":"A Fasano","year":"2012","unstructured":"Fasano, A. Leaky gut and autoimmune diseases. Clin. Rev. Allergy Immunol. 42, 71\u201378 (2012).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"727_CR73","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.autrev.2015.01.009","volume":"14","author":"A Lerner","year":"2015","unstructured":"Lerner, A. & Matthias, T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun. Rev. 14, 479\u2013489 (2015).","journal-title":"Autoimmun. Rev."},{"key":"727_CR74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/BOR.0000000000000574","volume":"31","author":"C Dehner","year":"2019","unstructured":"Dehner, C., Fine, R. & Kriegel, M. A. The microbiome in systemic autoimmune disease: mechanistic insights from recent studies. Curr. Opin. Rheumatol. 31, 201\u2013207 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"727_CR75","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.molmed.2020.04.001","volume":"26","author":"X Zhang","year":"2020","unstructured":"Zhang, X., Chen, B. D., Zhao, L. D. & Li, H. The gut microbiota: emerging evidence in autoimmune diseases. Trends Mol. Med. 26, 862\u2013873 (2020).","journal-title":"Trends Mol. Med."},{"key":"727_CR76","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/brain\/awp289","volume":"132","author":"V Brucklacher-Waldert","year":"2009","unstructured":"Brucklacher-Waldert, V., Stuerner, K., Kolster, M., Wolthausen, J. & Tolosa, E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 132, 3329\u20133341 (2009).","journal-title":"Brain"},{"key":"727_CR77","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbi.2017.03.008","volume":"64","author":"SM Restorick","year":"2017","unstructured":"Restorick, S. M. et al. CCR6+ Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells. Brain Behav. Immun. 64, 71\u201379 (2017).","journal-title":"Brain Behav. Immun."},{"key":"727_CR78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-2634-9","volume":"585","author":"E Miyauchi","year":"2020","unstructured":"Miyauchi, E. et al. Gut microorganisms act together to exacerbate inflammation in spinal cords. Nature 585, 102\u2013106 (2020).","journal-title":"Nature"},{"key":"727_CR79","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.celrep.2019.09.002","volume":"29","author":"D Duc","year":"2019","unstructured":"Duc, D. et al. Disrupting myelin-specific Th17 cell gut homing confers protection in an adoptive transfer experimental autoimmune encephalomyelitis. Cell Rep. 29, 378\u2013390.e4 (2019). Together with Miyauchi et al.78, this study demonstrates that transferred autoimmune T cells migrate into the gut and proliferate before infiltrating into the CNS.","journal-title":"Cell Rep."},{"key":"727_CR80","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1462-2920.2012.02731.x","volume":"14","author":"CL Thompson","year":"2012","unstructured":"Thompson, C. L., Vier, R., Mikaelyan, A., Wienemann, T. & Brune, A. \u2018Candidatus Arthromitus\u2019 revised: segmented filamentous bacteria in arthropod guts are members of Lachnospiraceae. Environ. Microbiol. 14, 1454\u20131465 (2012).","journal-title":"Environ. Microbiol."},{"key":"727_CR81","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485\u2013498 (2009).","journal-title":"Cell"},{"key":"727_CR82","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","volume":"163","author":"K Atarashi","year":"2015","unstructured":"Atarashi, K. et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367\u2013380 (2015).","journal-title":"Cell"},{"key":"727_CR83","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1073\/pnas.1000082107","volume":"108","author":"YK Lee","year":"2011","unstructured":"Lee, Y. K., Menezes, J. S., Umesaki, Y. & Mazmanian, S. K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 108, 4615\u20134622 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR84","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","volume":"32","author":"HJ Wu","year":"2010","unstructured":"Wu, H. J. et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815\u2013827 (2010).","journal-title":"Immunity"},{"key":"727_CR85","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/embj.201489966","volume":"34","author":"JT Van Praet","year":"2015","unstructured":"Van Praet, J. T. et al. Commensal microbiota influence systemic autoimmune responses. EMBO J. 34, 466\u2013474 (2015).","journal-title":"EMBO J."},{"key":"727_CR86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cell.2019.11.026","volume":"180","author":"JY Lee","year":"2020","unstructured":"Lee, J. Y. et al. Serum amyloid a proteins induce pathogenic Th17 cells and promote inflammatory disease. Cell 180, 79\u201391.e16 (2020).","journal-title":"Cell"},{"key":"727_CR87","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2015.08.061","volume":"163","author":"T Sano","year":"2015","unstructured":"Sano, T. et al. An IL-23R\/IL-22 circuit regulates epithelial serum amyloid a to promote local effector Th17 responses. Cell 163, 381\u2013393 (2015).","journal-title":"Cell"},{"key":"727_CR88","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1002\/art.21195","volume":"52","author":"ME Morgan","year":"2005","unstructured":"Morgan, M. E. et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52, 2212\u20132221 (2005).","journal-title":"Arthritis Rheum."},{"key":"727_CR89","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1002\/eji.201141503","volume":"41","author":"TS Davidson","year":"2011","unstructured":"Davidson, T. S. & Shevach, E. M. Polyclonal Treg cells modulate T effector cell trafficking. Eur. J. Immunol. 41, 2862\u20132870 (2011).","journal-title":"Eur. J. Immunol."},{"key":"727_CR90","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.4049\/jimmunol.181.7.4516","volume":"181","author":"DR Tonkin","year":"2008","unstructured":"Tonkin, D. R., He, J., Barbour, G. & Haskins, K. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo. J. Immunol. 181, 4516\u20134522 (2008).","journal-title":"J. Immunol."},{"key":"727_CR91","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/ar2511","volume":"10","author":"DA Horwitz","year":"2008","unstructured":"Horwitz, D. A. Regulatory T cells in systemic lupus erythematosus: past, present and future. Arthritis Res. Ther. 10, 227 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"727_CR92","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1002\/eji.200526065","volume":"35","author":"J Haas","year":"2005","unstructured":"Haas, J. et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35, 3343\u20133352 (2005).","journal-title":"Eur. J. Immunol."},{"key":"727_CR93","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","volume":"183","author":"JM Fletcher","year":"2009","unstructured":"Fletcher, J. M. et al. CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J. Immunol. 183, 7602\u20137610 (2009).","journal-title":"J. Immunol."},{"key":"727_CR94","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","volume":"180","author":"A Duscha","year":"2020","unstructured":"Duscha, A. et al. Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell 180, 1067\u20131080.e16 (2020). This study shows the therapeutic effects of the bacterial metabolite propionate in patients with MS.","journal-title":"Cell"},{"key":"727_CR95","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jnr.20522","volume":"81","author":"J Huan","year":"2005","unstructured":"Huan, J. et al. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81, 45\u201352 (2005).","journal-title":"J. Neurosci. Res."},{"key":"727_CR96","doi-asserted-by":"publisher","first-page":"22402","DOI":"10.1073\/pnas.2011703117","volume":"117","author":"D Takewaki","year":"2020","unstructured":"Takewaki, D. et al. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis. Proc. Natl Acad. Sci. USA 117, 22402\u201322412 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR97","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.immuni.2015.09.007","volume":"43","author":"A Haghikia","year":"2015","unstructured":"Haghikia, A. et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43, 817\u2013829 (2015).","journal-title":"Immunity"},{"key":"727_CR98","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/mi.2010.29","volume":"3","author":"J Ochoa-Reparaz","year":"2010","unstructured":"Ochoa-Reparaz, J. et al. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal. Immunol. 3, 487\u2013495 (2010).","journal-title":"Mucosal. Immunol."},{"key":"727_CR99","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.cell.2017.01.022","volume":"168","author":"N Geva-Zatorsky","year":"2017","unstructured":"Geva-Zatorsky, N. et al. Mining the human gut microbiota for immunomodulatory organisms. Cell 168, 928\u2013943.e11 (2017).","journal-title":"Cell"},{"key":"727_CR100","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4161\/gmic.29797","volume":"5","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. A commensal bacterial product elicits and modulates migratory capacity of CD39+ CD4 T regulatory subsets in the suppression of neuroinflammation. Gut Microbes 5, 552\u2013561 (2014).","journal-title":"Gut Microbes"},{"key":"727_CR101","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.trsl.2016.07.016","volume":"179","author":"J Ochoa-Reparaz","year":"2017","unstructured":"Ochoa-Reparaz, J. & Kasper, L. H. The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease. Transl. Res. 179, 126\u2013138 (2017).","journal-title":"Transl. Res."},{"key":"727_CR102","doi-asserted-by":"publisher","first-page":"e21386","DOI":"10.1371\/journal.pone.0021386","volume":"6","author":"D Dalla Libera","year":"2011","unstructured":"Dalla Libera, D. et al. T regulatory cells are markers of disease activity in multiple sclerosis patients. PLoS One 6, e21386 (2011).","journal-title":"PLoS One"},{"key":"727_CR103","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.1424792112","volume":"112","author":"RS Peres","year":"2015","unstructured":"Peres, R. S. et al. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 112, 2509\u20132514 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR104","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/1753-0407.12870","volume":"11","author":"X Jin","year":"2019","unstructured":"Jin, X. et al. Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients. J. Diabetes 11, 440\u2013448 (2019).","journal-title":"J. Diabetes"},{"key":"727_CR105","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cellimm.2011.06.010","volume":"271","author":"MJ Loza","year":"2011","unstructured":"Loza, M. J., Anderson, A. S., O\u2019Rourke, K. S., Wood, J. & Khan, I. U. T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus. Cell Immunol. 271, 110\u2013117 (2011).","journal-title":"Cell Immunol."},{"key":"727_CR106","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/JCI17935","volume":"112","author":"N Najafian","year":"2003","unstructured":"Najafian, N. et al. Regulatory functions of CD8+CD28\u2212 T cells in an autoimmune disease model. J. Clin. Invest. 112, 1037\u20131048 (2003).","journal-title":"J. Clin. Invest."},{"key":"727_CR107","doi-asserted-by":"publisher","first-page":"825","DOI":"10.4049\/jimmunol.180.2.825","volume":"180","author":"YH Lee","year":"2008","unstructured":"Lee, Y. H. et al. Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J. Immunol. 180, 825\u2013832 (2008).","journal-title":"J. Immunol."},{"key":"727_CR108","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ana.21067","volume":"61","author":"J Correale","year":"2007","unstructured":"Correale, J. & Farez, M. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 61, 97\u2013108 (2007).","journal-title":"Ann. Neurol."},{"key":"727_CR109","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2174\/1573399812666160427104157","volume":"13","author":"G Fousteri","year":"2017","unstructured":"Fousteri, G., Ippolito, E., Ahmed, R. & Hamad, A. R. A. Beta-cell specific autoantibodies: are they just an indicator of type 1 diabetes? Curr. Diabetes Rev. 13, 322\u2013329 (2017).","journal-title":"Curr. Diabetes Rev."},{"key":"727_CR110","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.3390\/ijms21134660","volume":"21","author":"HF Chang","year":"2020","unstructured":"Chang, H. F., Wirkner, M. L., Krause, E. & Rettig, J. Investigation of cytotoxic T lymphocyte function during allorejection in the anterior chamber of the eye. Int. J. Mol. Sci. 21, 4660 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"727_CR111","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1002\/eji.1830231244","volume":"23","author":"J Katz","year":"1993","unstructured":"Katz, J., Benoist, C. & Mathis, D. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23, 3358\u20133360 (1993).","journal-title":"Eur. J. Immunol."},{"key":"727_CR112","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/01.TP.0000118410.61419.59","volume":"77","author":"L Makhlouf","year":"2004","unstructured":"Makhlouf, L. et al. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice. Transplantation 77, 990\u2013997 (2004).","journal-title":"Transplantation"},{"key":"727_CR113","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/eji.1830250430","volume":"25","author":"D Daniel","year":"1995","unstructured":"Daniel, D., Gill, R. G., Schloot, N. & Wegmann, D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25, 1056\u20131062 (1995).","journal-title":"Eur. J. Immunol."},{"key":"727_CR114","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","volume":"127","author":"A Pugliese","year":"2017","unstructured":"Pugliese, A. Autoreactive T cells in type 1 diabetes. J. Clin. Invest. 127, 2881\u20132891 (2017).","journal-title":"J. Clin. Invest."},{"key":"727_CR115","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.4049\/jimmunol.179.4.2082","volume":"179","author":"M Kobayashi","year":"2007","unstructured":"Kobayashi, M. et al. Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes. J. Immunol. 179, 2082\u20132088 (2007).","journal-title":"J. Immunol."},{"key":"727_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22052-y","volume":"8","author":"L Xiao","year":"2018","unstructured":"Xiao, L. et al. Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice. Sci. Rep. 8, 3829 (2018).","journal-title":"Sci. Rep."},{"key":"727_CR117","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.immuni.2015.07.013","volume":"43","author":"J Sun","year":"2015","unstructured":"Sun, J. et al. Pancreatic beta-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 43, 304\u2013317 (2015). This study shows how gut microbiota manipulations can affect pancreatic immune system and disease development in NOD mice.","journal-title":"Immunity"},{"key":"727_CR118","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3109\/08916930903213993","volume":"42","author":"EF Young","year":"2009","unstructured":"Young, E. F., Hess, P. R., Arnold, L. W., Tisch, R. & Frelinger, J. A. Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct. Autoimmunity 42, 678\u2013691 (2009).","journal-title":"Autoimmunity"},{"key":"727_CR119","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/mi.2017.118","volume":"11","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal. Immunol. 11, 752\u2013762 (2018).","journal-title":"Mucosal. Immunol."},{"key":"727_CR120","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2016.04.003","volume":"22","author":"S Becattini","year":"2016","unstructured":"Becattini, S., Taur, Y. & Pamer, E. G. Antibiotic-induced changes in the intestinal microbiota and disease. Trends Mol. Med. 22, 458\u2013478 (2016).","journal-title":"Trends Mol. Med."},{"key":"727_CR121","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.1073\/pnas.1508740112","volume":"112","author":"MP Burrows","year":"2015","unstructured":"Burrows, M. P., Volchkov, P., Kobayashi, K. S. & Chervonsky, A. V. Microbiota regulates type 1 diabetes through Toll-like receptors. Proc. Natl Acad. Sci. USA 112, 9973\u20139977 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR122","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/ni.3713","volume":"18","author":"E Marino","year":"2017","unstructured":"Marino, E. et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat. Immunol. 18, 552\u2013562 (2017). Together wih Sun et al.117, the authors explain the effects of SCFAs on the autoimmunity and disease progression using NOD mice.","journal-title":"Nat. Immunol."},{"key":"727_CR123","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature07336","volume":"455","author":"L Wen","year":"2008","unstructured":"Wen, L. et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455, 1109\u20131113 (2008).","journal-title":"Nature"},{"key":"727_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15857-x","volume":"11","author":"C Shimokawa","year":"2020","unstructured":"Shimokawa, C. et al. CD8+ regulatory T cells are critical in prevention of autoimmune-mediated diabetes. Nat. Commun. 11, 1922 (2020).","journal-title":"Nat. Commun."},{"key":"727_CR125","doi-asserted-by":"publisher","first-page":"11548","DOI":"10.1073\/pnas.1108924108","volume":"108","author":"MA Kriegel","year":"2011","unstructured":"Kriegel, M. A. et al. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl Acad. Sci. USA 108, 11548\u201311553 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR126","doi-asserted-by":"publisher","first-page":"9754060","DOI":"10.1155\/2018\/9754060","volume":"2018","author":"MM Mutengo","year":"2018","unstructured":"Mutengo, M. M. et al. Low IL-6, IL-10, and TNF-alpha and high IL-13 cytokine levels are associated with severe hepatic fibrosis in Schistosoma mansoni chronically exposed individuals. J. Parasitol. Res. 2018, 9754060 (2018).","journal-title":"J. Parasitol. Res."},{"key":"727_CR127","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fimmu.2017.00453","volume":"8","author":"TB Smallwood","year":"2017","unstructured":"Smallwood, T. B. et al. Helminth immunomodulation in autoimmune disease. Front. Immunol. 8, 453 (2017).","journal-title":"Front. Immunol."},{"key":"727_CR128","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jaci.2016.07.007","volume":"138","author":"RM Maizels","year":"2016","unstructured":"Maizels, R. M. & McSorley, H. J. Regulation of the host immune system by helminth parasites. J. Allergy Clin. Immunol. 138, 666\u2013675 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"727_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01651-1","volume":"7","author":"FE Lumb","year":"2017","unstructured":"Lumb, F. E. et al. Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62. Sci. Rep. 7, 1704 (2017).","journal-title":"Sci. Rep."},{"key":"727_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09361-0","volume":"10","author":"J Doonan","year":"2019","unstructured":"Doonan, J. et al. The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis. Nat. Commun. 10, 1554 (2019). Together with Shimokawa et al.124, this study provides the mechanistic insights into how gut parasites exert protective effects on ADs.","journal-title":"Nat. Commun."},{"key":"727_CR131","doi-asserted-by":"publisher","first-page":"102057","DOI":"10.1016\/j.parint.2020.102057","volume":"76","author":"A Olia","year":"2020","unstructured":"Olia, A., Shimokawa, C., Imai, T., Suzue, K. & Hisaeda, H. Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstoma. Parasitol. Int. 76, 102057 (2020).","journal-title":"Parasitol. Int."},{"key":"727_CR132","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pt.2018.10.007","volume":"35","author":"TP Jenkins","year":"2019","unstructured":"Jenkins, T. P., Brindley, P. J., Gasser, R. B. & Cantacessi, C. Helminth microbiomes \u2014 a hidden treasure trove? Trends Parasitol. 35, 13\u201322 (2019).","journal-title":"Trends Parasitol."},{"key":"727_CR133","doi-asserted-by":"publisher","first-page":"e0182205","DOI":"10.1371\/journal.pone.0182205","volume":"12","author":"L Wegener Parfrey","year":"2017","unstructured":"Wegener Parfrey, L. et al. A benign helminth alters the host immune system and the gut microbiota in a rat model system. PLoS One 12, e0182205 (2017).","journal-title":"PLoS One"},{"key":"727_CR134","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.immuni.2012.10.021","volume":"38","author":"LF Su","year":"2013","unstructured":"Su, L. F., Kidd, B. A., Han, A., Kotzin, J. J. & Davis, M. M. Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults. Immunity 38, 373\u2013383 (2013).","journal-title":"Immunity"},{"key":"727_CR135","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1053\/j.gastro.2017.07.047","volume":"153","author":"AN Hegazy","year":"2017","unstructured":"Hegazy, A. N. et al. Circulating and tissue-resident CD4+ T cells with reactivity to intestinal microbiota are abundant in healthy individuals and function is altered during inflammation. Gastroenterology 153, 1320\u20131337.e16 (2017).","journal-title":"Gastroenterology"},{"key":"727_CR136","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1073\/pnas.1405634111","volume":"111","author":"AM Morton","year":"2014","unstructured":"Morton, A. M. et al. Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut. Proc. Natl Acad. Sci. USA 111, 6696\u20136701 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR137","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2016.03.013","volume":"44","author":"F Teng","year":"2016","unstructured":"Teng, F. et al. Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer\u2019s Patch T follicular helper cells. Immunity 44, 875\u2013888 (2016).","journal-title":"Immunity"},{"key":"727_CR138","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.immuni.2016.10.020","volume":"45","author":"CF Krebs","year":"2016","unstructured":"Krebs, C. F. et al. Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney. Immunity 45, 1078\u20131092 (2016).","journal-title":"Immunity"},{"key":"727_CR139","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/brain\/awz012","volume":"142","author":"A Kadowaki","year":"2019","unstructured":"Kadowaki, A., Saga, R., Lin, Y., Sato, W. & Yamamura, T. Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis. Brain 142, 916\u2013931 (2019).","journal-title":"Brain"},{"key":"727_CR140","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1073\/pnas.1705599114","volume":"114","author":"H Yu","year":"2017","unstructured":"Yu, H. et al. Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development. Proc. Natl Acad. Sci. USA 114, 10443\u201310448 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76109-y","volume":"10","author":"N Jacob","year":"2020","unstructured":"Jacob, N. et al. Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes. Sci. Rep. 10, 19120 (2020).","journal-title":"Sci. Rep."},{"key":"727_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13731-z","volume":"10","author":"C Luckel","year":"2019","unstructured":"Luckel, C. et al. IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis. Nat. Commun. 10, 5722 (2019).","journal-title":"Nat. Commun."},{"key":"727_CR143","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1474-4422(17)30007-8","volume":"16","author":"T Kalincik","year":"2017","unstructured":"Kalincik, T. et al. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. Lancet Neurol. 16, 271\u2013281 (2017).","journal-title":"Lancet Neurol."},{"key":"727_CR144","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41591-019-0568-2","volume":"25","author":"A Cassotta","year":"2019","unstructured":"Cassotta, A. et al. A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients. Nat. Med. 25, 1402\u20131407 (2019).","journal-title":"Nat. Med."},{"key":"727_CR145","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","volume":"376","author":"SL Hauser","year":"2017","unstructured":"Hauser, S. L. et al. Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. N. Engl. J. Med. 376, 221\u2013234 (2017).","journal-title":"N. Engl. J. Med."},{"key":"727_CR146","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1212\/WNL.0000000000001608","volume":"84","author":"DM Hartung","year":"2015","unstructured":"Hartung, D. M., Bourdette, D. N., Ahmed, S. M. & Whitham, R. H. The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail? Neurology 84, 2185\u20132192 (2015).","journal-title":"Neurology"},{"key":"727_CR147","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nrneurol.2017.2","volume":"13","author":"B Hemmer","year":"2017","unstructured":"Hemmer, B. & Muhlau, M. Multiple sclerosis in 2016: immune-directed therapies in MS \u2014 efficacy and limitations. Nat. Rev. Neurol. 13, 72\u201374 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"727_CR148","doi-asserted-by":"publisher","first-page":"24922","DOI":"10.1073\/pnas.1918897116","volume":"116","author":"ID Duncan","year":"2019","unstructured":"Duncan, I. D. & Watters, J. J. Remyelination and the gut-brain axis. Proc. Natl Acad. Sci. USA 116, 24922\u201324924 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR149","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/glia.23167","volume":"65","author":"V Schultz","year":"2017","unstructured":"Schultz, V. et al. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination. Glia 65, 1350\u20131360 (2017).","journal-title":"Glia"},{"key":"727_CR150","doi-asserted-by":"publisher","first-page":"25311","DOI":"10.1073\/pnas.1905787116","volume":"116","author":"CE McMurran","year":"2019","unstructured":"McMurran, C. E. et al. The microbiota regulates murine inflammatory responses to toxin-induced CNS demyelination but has minimal impact on remyelination. Proc. Natl Acad. Sci. USA 116, 25311\u201325321 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR151","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1462-2920.13589","volume":"19","author":"P Louis","year":"2017","unstructured":"Louis, P. & Flint, H. J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29\u201341 (2017).","journal-title":"Environ. Microbiol."},{"key":"727_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1552-y","volume":"16","author":"T Chen","year":"2019","unstructured":"Chen, T., Noto, D., Hoshino, Y., Mizuno, M. & Miyake, S. Butyrate suppresses demyelination and enhances remyelination. J. Neuroinflammation 16, 165 (2019).","journal-title":"J. Neuroinflammation"},{"key":"727_CR153","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/cells9040906","volume":"9","author":"L Calvo-Barreiro","year":"2020","unstructured":"Calvo-Barreiro, L. et al. A commercial probiotic induces tolerogenic and reduces pathogenic responses in experimental autoimmune encephalomyelitis. Cells 9, 906 (2020).","journal-title":"Cells"},{"key":"727_CR154","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fimmu.2019.00385","volume":"10","author":"B He","year":"2019","unstructured":"He, B. et al. Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota. Front. Immunol. 10, 385 (2019).","journal-title":"Front. Immunol."},{"key":"727_CR155","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.clim.2013.01.001","volume":"146","author":"HK Kwon","year":"2013","unstructured":"Kwon, H. K. et al. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clin. Immunol. 146, 217\u2013227 (2013).","journal-title":"Clin. Immunol."},{"key":"727_CR156","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3920\/BM2020.0012","volume":"11","author":"JE Libbey","year":"2020","unstructured":"Libbey, J. E. et al. Modulation of experimental autoimmune encephalomyelitis through colonisation of the gut with Escherichia coli. Benef. Microbes 11, 669\u2013684 (2020).","journal-title":"Benef. Microbes"},{"key":"727_CR157","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/1352458517737390","volume":"24","author":"SK Tankou","year":"2018","unstructured":"Tankou, S. K. et al. Investigation of probiotics in multiple sclerosis. Mult. Scler. 24, 58\u201363 (2018).","journal-title":"Mult. Scler."},{"key":"727_CR158","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.clnu.2016.08.015","volume":"36","author":"E Kouchaki","year":"2017","unstructured":"Kouchaki, E. et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin. Nutr. 36, 1245\u20131249 (2017).","journal-title":"Clin. Nutr."},{"key":"727_CR159","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","volume":"174","author":"N Zmora","year":"2018","unstructured":"Zmora, N. et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174, 1388\u20131405.e21 (2018).","journal-title":"Cell"},{"key":"727_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01766-9","volume":"17","author":"C Godel","year":"2020","unstructured":"Godel, C. et al. Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease. J. Neuroinflammation 17, 79 (2020).","journal-title":"J. Neuroinflammation"},{"key":"727_CR161","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/jnc.13871","volume":"139","author":"K Ma","year":"2016","unstructured":"Ma, K. et al. Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses. J. Neurochem. 139, 1151\u20131162 (2016).","journal-title":"J. Neurochem."},{"key":"727_CR162","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/08820130903062194","volume":"38","author":"D Wang","year":"2009","unstructured":"Wang, D., Lu, Z., Hu, L., Zhang, Y. & Hu, X. Macrolide antibiotics aggravate experimental autoimmune encephalomyelitis and inhibit inducible nitric oxide synthase. Immunol. Invest. 38, 602\u2013612 (2009).","journal-title":"Immunol. Invest."},{"key":"727_CR163","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ane.12958","volume":"138","author":"I Abdollahpour","year":"2018","unstructured":"Abdollahpour, I., Nedjat, S., Mansournia, M. A., Eckert, S. & Weinstock-Guttman, B. Infectious exposure, antibiotic use, and multiple sclerosis: a population-based incident case-control study. Acta Neurol. Scand. 138, 308\u2013314 (2018).","journal-title":"Acta Neurol. Scand."},{"key":"727_CR164","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.21873\/invivo.12186","volume":"34","author":"G TernAk","year":"2020","unstructured":"TernAk, G. et al. Dominant antibiotic consumption patterns might be associated with the prevalence of multiple sclerosis in European countries. Vivo 34, 3467\u20133472 (2020).","journal-title":"Vivo"},{"key":"727_CR165","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000515682","volume":"55","author":"E Baldin","year":"2021","unstructured":"Baldin, E. et al. Antibiotic use and risk of multiple sclerosis: a nested case-control study in Emilia-Romagna region, Italy. Neuroepidemiology 55, 224\u2013231 (2021).","journal-title":"Neuroepidemiology"},{"key":"727_CR166","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"Global Burden of Disease Study.","year":"2019","unstructured":"Global Burden of Disease Study. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 269\u2013285 (2019).","journal-title":"Lancet Neurol."},{"key":"727_CR167","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/ni0111-5","volume":"12","author":"KM Maslowski","year":"2011","unstructured":"Maslowski, K. M. & Mackay, C. R. Diet, gut microbiota and immune responses. Nat. Immunol. 12, 5\u20139 (2011).","journal-title":"Nat. Immunol."},{"key":"727_CR168","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3389\/fimmu.2017.00838","volume":"8","author":"D Statovci","year":"2017","unstructured":"Statovci, D., Aguilera, M., MacSharry, J. & Melgar, S. The impact of western diet and nutrients on the microbiota and immune response at mucosal interfaces. Front. Immunol. 8, 838 (2017).","journal-title":"Front. Immunol."},{"key":"727_CR169","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cmet.2014.07.003","volume":"20","author":"ED Sonnenburg","year":"2014","unstructured":"Sonnenburg, E. D. & Sonnenburg, J. L. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 20, 779\u2013786 (2014).","journal-title":"Cell Metab."},{"key":"727_CR170","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1212\/WNL.0000000000004768","volume":"90","author":"KC Fitzgerald","year":"2018","unstructured":"Fitzgerald, K. C. et al. Diet quality is associated with disability and symptom severity in multiple sclerosis. Neurology 90, e1\u2013e11 (2018).","journal-title":"Neurology"},{"key":"727_CR171","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0140-6736(90)91533-G","volume":"336","author":"RL Swank","year":"1990","unstructured":"Swank, R. L. & Dugan, B. B. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 336, 37\u201339 (1990).","journal-title":"Lancet"},{"key":"727_CR172","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/jnnp-2014-307928","volume":"86","author":"MF Farez","year":"2015","unstructured":"Farez, M. F., Fiol, M. P., Gaitan, M. I., Quintana, F. J. & Correale, J. Sodium intake is associated with increased disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 86, 26\u201331 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"727_CR173","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/brain\/awp033","volume":"132","author":"J Correale","year":"2009","unstructured":"Correale, J., Ysrraelit, M. C. & Gaitan, M. I. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132, 1146\u20131160 (2009).","journal-title":"Brain"},{"key":"727_CR174","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature11984","volume":"496","author":"C Wu","year":"2013","unstructured":"Wu, C. et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513\u2013517 (2013).","journal-title":"Nature"},{"key":"727_CR175","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11481-013-9502-4","volume":"9","author":"S Timmermans","year":"2014","unstructured":"Timmermans, S. et al. High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the renin angiotensin system. J. Neuroimmune. Pharmacol. 9, 209\u2013217 (2014).","journal-title":"J. Neuroimmune. Pharmacol."},{"key":"727_CR176","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"727_CR177","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson, G. R. et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 14, 491\u2013502 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"727_CR178","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.3390\/ijms22136855","volume":"22","author":"A Steimle","year":"2021","unstructured":"Steimle, A., Neumann, M., Grant, E. T., Turner, J. D. & Desai, M. S. Concentrated raw fibers enhance the fiber-degrading capacity of a synthetic human gut microbiome. Int. J. Mol. Sci. 22, 6855 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"727_CR179","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-food-041715-033159","volume":"7","author":"SA Joyce","year":"2016","unstructured":"Joyce, S. A. & Gahan, C. G. Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health. Annu. Rev. Food Sci. Technol. 7, 313\u2013333 (2016).","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"727_CR180","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1073\/pnas.1005963107","volume":"107","author":"C De Filippo","year":"2010","unstructured":"De Filippo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. USA 107, 14691\u201314696 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR181","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1086\/525047","volume":"197","author":"JY Chang","year":"2008","unstructured":"Chang, J. Y. et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197, 435\u2013438 (2008).","journal-title":"J. Infect. Dis."},{"key":"727_CR182","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/apt.14201","volume":"46","author":"MN Quraishi","year":"2017","unstructured":"Quraishi, M. N. et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment. Pharmacol. Ther. 46, 479\u2013493 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"727_CR183","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.1212\/NXI.0000000000000459","volume":"5","author":"S Makkawi","year":"2018","unstructured":"Makkawi, S., Camara-Lemarroy, C. & Metz, L. Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS. Neurol. Neuroimmunol. Neuroinflamm. 5, e459 (2018).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"727_CR184","first-page":"S352","volume":"106","author":"T Borody","year":"2011","unstructured":"Borody, T., Leis, S., Campbell, J., Margaux, T. & Anna, N. Fecal microbiota transplantation (FMT) in multiple sclerosis (MS). Am. J. Gastoenterol. 106, S352 (2011).","journal-title":"Am. J. Gastoenterol."},{"key":"727_CR185","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcimb.2019.00002","volume":"9","author":"BC Wilson","year":"2019","unstructured":"Wilson, B. C., Vatanen, T., Cutfield, W. S. & O\u2019Sullivan, J. M. The super-donor phenomenon in fecal microbiota transplantation. Front. Cell Infect. Microbiol. 9, 2 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"727_CR186","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41575-021-00512-7","volume":"18","author":"M Wolter","year":"2021","unstructured":"Wolter, M. et al. Leveraging diet to engineer the gut microbiome. Nat. Rev. Gastroenterol. Hepatol. 18, 885\u2013902 (2021). This review article summarizes the potential of manipulation of the gut microbiota by diet and dietary supplementation for ADs.","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"727_CR187","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.celrep.2016.05.009","volume":"15","author":"IY Choi","year":"2016","unstructured":"Choi, I. Y. et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep. 15, 2136\u20132146 (2016).","journal-title":"Cell Rep."},{"key":"727_CR188","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.msard.2016.07.001","volume":"9","author":"V Yadav","year":"2016","unstructured":"Yadav, V. et al. Low-fat, plant-based diet in multiple sclerosis: a randomized controlled trial. Mult. Scler. Relat. Disord. 9, 80\u201390 (2016).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"727_CR189","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/ana.25244","volume":"83","author":"SK Tankou","year":"2018","unstructured":"Tankou, S. K. et al. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann. Neurol. 83, 1147\u20131161 (2018).","journal-title":"Ann. Neurol."},{"key":"727_CR190","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1126\/science.aaf7419","volume":"352","author":"GM Birchenough","year":"2016","unstructured":"Birchenough, G. M., Nystrom, E. E., Johansson, M. E. & Hansson, G. C. A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science 352, 1535\u20131542 (2016).","journal-title":"Science"},{"key":"727_CR191","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.ymthe.2019.07.007","volume":"27","author":"A Steimle","year":"2019","unstructured":"Steimle, A. et al. Weak agonistic LPS restores intestinal immune homeostasis. Mol. Ther. 27, 1974\u20131991 (2019).","journal-title":"Mol. Ther."},{"key":"727_CR192","doi-asserted-by":"publisher","first-page":"e3000334","DOI":"10.1371\/journal.pbio.3000334","volume":"17","author":"A Steimle","year":"2019","unstructured":"Steimle, A. et al. Flagellin hypervariable region determines symbiotic properties of commensal Escherichia coli strains. PLoS Biol. 17, e3000334 (2019).","journal-title":"PLoS Biol."},{"key":"727_CR193","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2013.05.012","volume":"148","author":"B Teixeira","year":"2013","unstructured":"Teixeira, B. et al. Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels. Clin. Immunol. 148, 209\u2013218 (2013).","journal-title":"Clin. Immunol."},{"key":"727_CR194","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","volume":"76","author":"F Ciccia","year":"2017","unstructured":"Ciccia, F. et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann. Rheum. Dis. 76, 1123\u20131132 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"727_CR195","first-page":"5153","volume":"8","author":"R Lin","year":"2015","unstructured":"Lin, R., Zhou, L., Zhang, J. & Wang, B. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. Int. J. Clin. Exp. Pathol. 8, 5153\u20135160 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"727_CR196","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fimmu.2019.00658","volume":"10","author":"P Ayyappan","year":"2019","unstructured":"Ayyappan, P., Harms, R. Z., Buckner, J. H. & Sarvetnick, N. E. Coordinated induction of antimicrobial response factors in systemic lupus erythematosus. Front. Immunol. 10, 658 (2019).","journal-title":"Front. Immunol."},{"key":"727_CR197","doi-asserted-by":"publisher","first-page":"573079","DOI":"10.3389\/fimmu.2020.573079","volume":"11","author":"E Marietta","year":"2020","unstructured":"Marietta, E., Mangalam, A. K., Taneja, V. & Murray, J. A. Intestinal dysbiosis in, and enteral bacterial therapies for, systemic autoimmune diseases. Front. Immunol. 11, 573079 (2020).","journal-title":"Front. Immunol."},{"key":"727_CR198","doi-asserted-by":"publisher","first-page":"13064","DOI":"10.1073\/pnas.1120585109","volume":"109","author":"JM Reynolds","year":"2012","unstructured":"Reynolds, J. M., Martinez, G. J., Chung, Y. & Dong, C. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc. Natl Acad. Sci. USA 109, 13064\u201313069 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR199","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.4049\/jimmunol.0802656","volume":"182","author":"JR Nichols","year":"2009","unstructured":"Nichols, J. R. et al. TLR2 deficiency leads to increased Th17 infiltrates in experimental brain abscesses. J. Immunol. 182, 7119\u20137130 (2009).","journal-title":"J. Immunol."},{"key":"727_CR200","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1073\/pnas.0813037106","volume":"106","author":"T Hayashi","year":"2009","unstructured":"Hayashi, T. et al. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7. Proc. Natl Acad. Sci. USA 106, 2764\u20132769 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR201","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fimmu.2016.00191","volume":"7","author":"A Piermattei","year":"2016","unstructured":"Piermattei, A. et al. Toll-like receptor 2 mediates in vivo pro- and anti-inflammatory effects of mycobacterium tuberculosis and modulates autoimmune encephalomyelitis. Front. Immunol. 7, 191 (2016).","journal-title":"Front. Immunol."},{"key":"727_CR202","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0966-842X(03)00006-4","volume":"11","author":"AP Kohm","year":"2003","unstructured":"Kohm, A. P., Fuller, K. G. & Miller, S. D. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol. 11, 101\u2013105 (2003).","journal-title":"Trends Microbiol."},{"key":"727_CR203","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/nm1097-1133","volume":"3","author":"SD Miller","year":"1997","unstructured":"Miller, S. D. et al. Persistent infection with Theiler\u2019s virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3, 1133\u20131136 (1997).","journal-title":"Nat. Med."},{"key":"727_CR204","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1172\/JCI200113032","volume":"108","author":"JK Olson","year":"2001","unstructured":"Olson, J. K., Croxford, J. L., Calenoff, M. A., Dal Canto, M. C. & Miller, S. D. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 108, 311\u2013318 (2001).","journal-title":"J. Clin. Invest."},{"key":"727_CR205","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1172\/JCI93450","volume":"127","author":"A Pianta","year":"2017","unstructured":"Pianta, A. et al. Two rheumatoid arthritis-specific autoantigens correlate microbial immunity with autoimmune responses in joints. J. Clin. Invest. 127, 2946\u20132956 (2017).","journal-title":"J. Clin. Invest."},{"key":"727_CR206","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle, M. R. et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349, 1526\u20131533 (2003).","journal-title":"N. Engl. J. Med."},{"key":"727_CR207","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.2414848","volume":"230","author":"RS Fujinami","year":"1985","unstructured":"Fujinami, R. S. & Oldstone, M. B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230, 1043\u20131045 (1985).","journal-title":"Science"},{"key":"727_CR208","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.immuni.2009.01.009","volume":"30","author":"M Harkiolaki","year":"2009","unstructured":"Harkiolaki, M. et al. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 30, 348\u2013357 (2009).","journal-title":"Immunity"},{"key":"727_CR209","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nri.2017.55","volume":"17","author":"ID Iliev","year":"2017","unstructured":"Iliev, I. D. & Leonardi, I. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat. Rev. Immunol. 17, 635\u2013646 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"727_CR210","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol, H. et al. Fungal microbiota dysbiosis in IBD. Gut 66, 1039\u20131048 (2017).","journal-title":"Gut"},{"key":"727_CR211","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut, B. et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature 574, 264\u2013267 (2019).","journal-title":"Nature"},{"key":"727_CR212","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12016-012-8344-9","volume":"45","author":"M Rinaldi","year":"2013","unstructured":"Rinaldi, M., Perricone, R., Blank, M., Perricone, C. & Shoenfeld, Y. Anti-Saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity. Clin. Rev. Allergy Immunol. 45, 152\u2013161 (2013).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"727_CR213","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1053\/j.gastro.2006.02.009","volume":"130","author":"A Standaert-Vitse","year":"2006","unstructured":"Standaert-Vitse, A. et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn\u2019s disease. Gastroenterology 130, 1764\u20131775 (2006).","journal-title":"Gastroenterology"},{"key":"727_CR214","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2019.01.041","volume":"176","author":"P Bacher","year":"2019","unstructured":"Bacher, P. et al. Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans. Cell 176, 1340\u20131355.e15 (2019).","journal-title":"Cell"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-022-00727-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-022-00727-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-022-00727-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T09:18:11Z","timestamp":1672737491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-022-00727-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":214,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1038\/s41577-022-00727-y","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"20 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S.D. works as a consultant and advisory board member at Theralution GmbH, Germany. The other authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}